Effect of Adjuvant/Neoadjuvant Trastuzumab on Clinical Outcomes in Patients With HER2-Positive Metastatic Breast CancerMURTHY, Rashmi K; VARMA, Ankur; BOOSER, Daniel et al.Cancer. 2014, Vol 120, Num 13, pp 1932-1938, issn 0008-543X, 7 p.Article

A Phase 1 Study of Weekly Everolimus (RAD001) in Combination With Docetaxel in Patients With Metastatic Breast CancerMOULDER, Stacy; GLADISH, Gregory; RIVERA, Edgardo et al.Cancer. 2012, Vol 118, Num 9, pp 2378-2384, issn 0008-543X, 7 p.Article

A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancersTRENT, Jonathan C; VALERO, Vicente; CRISTOFANILLI, Massimo et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2426-2434, issn 1078-0432, 9 p.Article

Phase I trial of intratumoral liposome E1A Gene therapy in patients with recurrent breast and head and neck cancerYOO, George H; HUNG, Mien-Chie; LOPEZ-BERESTEIN, Gabriel et al.Clinical cancer research. 2001, Vol 7, Num 5, pp 1237-1245, issn 1078-0432Article

Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerMURRAY, James L; THOMPSON, Patricia; SUK YOUNG YOO et al.Breast cancer research and treatment. 2013, Vol 138, Num 3, pp 917-924, issn 0167-6806, 8 p.Article

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancerGILLOGLY, Michael E; KALLINTERIS, Nikoletta L; MINZHEN XU et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 6, pp 490-496, issn 0340-7004, 7 p.Article

Safety of yttrium-90 ibritumomab tiuxetan Radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphomaWITZIG, Thomas E; WHITE, Christine A; GORDON, Leo I et al.Journal of clinical oncology. 2003, Vol 21, Num 7, pp 1263-1270, issn 0732-183X, 8 p.Article

Clinical studies of vaccines targeting breast cancerKO, Byung K; KAWANO, Kouichiro; MURRAY, James L et al.Clinical cancer research. 2003, Vol 9, Num 9, pp 3222-3234, issn 1078-0432, 13 p.Article

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancerRIVERA, Edgardo; VALERO, Vicente; HORTOBAGYI, Gabriel N et al.Journal of clinical oncology. 2001, Vol 19, Num 6, pp 1716-1722, issn 0732-183XArticle

Phase I-II vinorelbine (Navelbine®) by continuous infusion in patients with metastatic breast cancer : Cumulative toxicities limit dose escalationIBRAHIM, Nuhad K; VALERO, Vicente; BAST, Robert et al.Cancer investigation. 2001, Vol 19, Num 5, pp 459-466, issn 0735-7907Article

Monoclonal antibody treatment of solid tumors : A coming of ageMURRAY, James L.Seminars in oncology. 2000, Vol 27, Num 6, pp 64-70, issn 0093-7754, SUP11Conference Paper

Detection and Characterization of a Novel Subset of CD8⁺CD57⁺ T Cells in Metastatic Melanoma with an Incompletely Differentiated PhenotypeWU, Richard C; SHUJUAN LIU; LIZEE, Gregory et al.Clinical cancer research (Print). 2012, Vol 18, Num 9, pp 2465-2477, issn 1078-0432, 13 p.Article

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by ImmunohistochemistryIWAMOTO, Takayuki; BOOSER, Daniel; MATSUOKA, Junji et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 729-734, issn 0732-183X, 6 p.Article

Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1DZIUBA, Natallia; FERGUSON, Monique R; HODGE, Thomas W et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1329-1339, issn 0889-2229, 11 p.Article

Sensitivity of undifferentiated, high-TCR density CD8⁺ cells to methylene groups appended to tumor antigen determines their differentiation or deathKAWANO, Kouichiro; EFFERSON, Clay L; PEOPLES, George E et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2930-2937, issn 0008-5472, 8 p.Article

Immunotherapy for low-grade non-Hodgkin secondary lymphoma of the orbitESMAELI, Bita; MURRAY, James L; AHMUDI, M. Amir et al.Archives of ophthalmology (1960). 2002, Vol 120, Num 9, pp 1225-1227, issn 0003-9950Article

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trialWISEMAN, Gregory A; GORDON, Leo I; GRILLO-LOPEZ, Antonio J et al.Blood. 2002, Vol 99, Num 12, pp 4336-4342, issn 0006-4971Article

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancerESTEVA, Francisco J; VALERO, Vicente; SNEIGE, Nour et al.Journal of clinical oncology. 2002, Vol 20, Num 7, pp 1800-1808, issn 0732-183XArticle

A detailed evaluation of cardiac toxicity: A Phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancerGIORDANO, Sharon H; BOOSER, Daniel J; EWER, Michael et al.Clinical cancer research. 2002, Vol 8, Num 11, pp 3360-3368, issn 1078-0432, 9 p.Article

Relationship between epidemiologic risk factors and breast cancer recurrenceBREWSTER, Abenaa M; DO, Kim-Anh; THOMPSON, Patricia A et al.Journal of clinical oncology. 2007, Vol 25, Num 28, pp 4438-4444, issn 0732-183X, 7 p.Article

Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanomaMURRAY, James L; GILLOGLY, Michael; KAWANO, Kouichiro et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5481-5488, issn 0008-5472, 8 p.Article

Phase I study of Vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast CancerIBRAHIM, Nuhad K; RAHMAN, Zia; VALERO, Vicente et al.Cancer investigation. 2002, Vol 20, Num 1, pp 29-37, issn 0735-7907Article

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects : a phase I clinical trialHORTOBAGYI, Gabriel N; UENO, Naoto T; PAYNE, Joy Y et al.Journal of clinical oncology. 2001, Vol 19, Num 14, pp 3422-3433, issn 0732-183XArticle

Paclitaxel in the multimodality treatment for inflammatory breast carcinomaCRISTOFANILLI, Massimo; BUZDAR, Aman U; UENO, Naoto et al.Cancer. 2001, Vol 92, Num 7, pp 1775-1782, issn 0008-543XArticle

Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individualsANDERSON, Brett W; PEOPLES, George E; MURRAY, James L et al.Clinical cancer research. 2000, Vol 6, Num 11, pp 4192-4200, issn 1078-0432Article